1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 5,000 | 8,000 | 23.06. |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Do | ABL Diagnostics: Growth Trajectory Confirmed and Strong Upside Potential Identified | 262 | Business Wire | Target price: €8.7 Recommendation: Buy
Regulatory News:
ABL DIAGNOSTICS (FR001400AHX6 ABLD-FR), a leading company in the field of molecular diagnostics and genotyping, announces the... ► Artikel lesen | |
| 12.06. | ABL Diagnostics and CDL Pharma Secure a Multi-year International Contract of up to €2.7 Million Through 2031 | 328 | Business Wire | Regulatory News:
ABL Diagnostics (FR001400AHX6 "ABLD") announces the signing of a multi-year contract with a European pharmaceutical company in the field of neurodegenerative diseases. The contract... ► Artikel lesen | |
| 10.06. | ABL Diagnostics (ABLD) Announces the Submission of a Takeover Bid for Texcell France | 334 | Business Wire | Regulatory News:
ABL Diagnostics (Paris:ABLD) (Euronext Paris Compartment B ISIN: FR001400AHX6), a company specialized in molecular diagnostic solutions, healthcare software, and clinical sample... ► Artikel lesen | |
| 10.06. | ABL Diagnostics SA: ABL Diagnostics: Information Relating to the Total Number of Voting Rights and the Total Number of Shares Composing the Share Capital | 432 | Business Wire | (Articles L. 233-8, II of the French Commercial Code and 223-16 of the AMF General Regulation)
Regulatory News:
ABL Diagnostics (Paris:ABLD)
Date Total number of shares composing... ► Artikel lesen | |
| 09.06. | ABL Diagnostics: Ordinary and Extraordinary General Meeting of June 30, 2026 - Terms for Making Available or Consulting Preparatory Documents | 329 | Business Wire | Regulatory News:
ABL Diagnostics (Paris:ABLD) informs its shareholders that they are invited to attend the Ordinary and Extraordinary General Meeting to be held on Tuesday, June 30, 2026, at 11:00... ► Artikel lesen | |
| 05.06. | ABL Diagnostics SA: ABL Diagnostics: Sale of a new block of shares by its main shareholder ABL | 359 | Business Wire | Regulatory News:
ABL Diagnostics (Paris:ABLD) announces that its main shareholder, Advanced Biological Laboratories (ABL), a Luxembourg-based diagnostics company, has filed information with the... ► Artikel lesen | |
| 04.06. | ABL Diagnostics: Sale of a New Block of Shares by Its Main Shareholder ABL | 316 | Business Wire | Regulatory News:
ABL Diagnostics (Paris:ABLD) announces that its main shareholder, Advanced Biological Laboratories (ABL), a Luxembourg-based diagnostics company, has filed information with the... ► Artikel lesen | |
| ABL DIAGNOSTICS Aktie jetzt für 0€ handeln | |||||
| 01.06. | ABL Diagnostics Presents Its Financial Roadmap and Growth Outlook for 2026 | 284 | Business Wire | Full-year 2026 revenue target set at €12.27 million, delivering an exceptional +76.5% growth compared to 2025 Historic shift in scale driven by the full-year impact of growth drivers (FTD... ► Artikel lesen | |
| 19.05. | Allinvest Reiterates Its "BUY" Rating on ABL Diagnostics and Maintains a €8.4 Target Price (Representing a 2.2X Multiple) | 308 | Business Wire | Massive upside potential of +123.4% compared to the closing price of €3.76 (as of May 18, 2026). Historic 2025 results: Revenue up +30.4% to €6.95m, net profit surging to €0.98m (+246%)... ► Artikel lesen | |
| 18.05. | ABL Diagnostics SA: ABL Diagnostics Proposes a Significant Increase in Its Dividend for FY2025 | 285 | Business Wire | Proposed dividend of €0.11 per share, up +120%, reflecting the Company's improved financial performance and solid financial position
Regulatory News:
ABL Diagnostics (Euronext Paris FR001400AHX6)... ► Artikel lesen | |
| 11.05. | ABL Diagnostics Reports Historic 2025 Annual Results: Net Income Explosion (+246%), Strong Operating Profitability and Global Acceleration | 309 | Business Wire | Strong revenue growth of +30.4% to €6.95m Positive operating income of €290k, exceeding analyst forecasts Net income soaring to nearly €1m (€987k) International business acceleration:... ► Artikel lesen | |
| 08.05. | ABL Diagnostics: Availability of the 2025 Annual Financial Report | 393 | Business Wire | Regulatory News:
ABL Diagnostics (Paris:ABLD) announces that it has made its 2025 Annual Financial Report available to the public and filed it with the Autorité des marchés financiers (AMF).
The... ► Artikel lesen | |
| 17.03. | ABL Diagnostics: Sale of a New Block of Shares by Its Main Shareholder ABL | 359 | Business Wire | Regulatory News:
ABL Diagnostics (Paris:ABLD) announces that its main shareholder, Advanced Biological Laboratories (ABL), a Luxembourg-based diagnostics company, has filed information with the... ► Artikel lesen | |
| 19.02. | ABL Diagnostics S.A.: ABL Diagnostics Update Regarding Non-Binding Letter of Intent | 358 | Business Wire | Regulatory News:
ABL Diagnostics S.A. (Euronext: ABLD ISIN: FR001400AHX6) informs the market that the non-binding Letter of Intent entered into between ProPhase Labs, Inc. and Advanced Biological... ► Artikel lesen | |
| 13.02. | ABL Diagnostics SA: ABL SA Executes the First Purchase Notice of ABL Diagnostics Shares With Alumni Capital | 596 | Business Wire | Regulatory News:
ISIN: FR001400AHX6 Euronext Paris
ABL Diagnostics SA ("the Company") (Paris:ABLD) informs the public that its principal shareholder, Advanced Biological Laboratories SA (ABL... ► Artikel lesen | |
| 03.02. | ABL Diagnostics: Sale of a New Block of Shares by Its Main Shareholder ABL | 418 | Business Wire | Regulatory News:
ABL Diagnostics (Paris:ABLD) announces that its main shareholder, Advanced Biological Laboratories (ABL), a Luxembourg-based diagnostics company, has filed information with the... ► Artikel lesen | |
| 19.12.25 | ABL Diagnostics Informs the Market of a Non-Binding Letter of Intent Between ABL S.A. and ProPhase Labs (Nasdaq: PRPH) for a Proposed Reverse Merger | 480 | Business Wire | The contemplated transaction remains subject to due diligence, definitive agreements, regulatory approvals and Nasdaq listing requirements; no change to ABL S.A.'s control over ABL Diagnostics at... ► Artikel lesen | |
| 05.12.25 | ABL Diagnostics S.A.: Information on a Temporary Transfer of ABL Diagnostics Shares | 447 | Business Wire | Regulatory News:
ABL Diagnostics S.A. (ISIN: FR001400AHX6, ticker: ABLD, listed on Euronext Paris) informs its shareholders and the market that a temporary transfer of 128,026 shares of the company... ► Artikel lesen | |
| 14.11.25 | ABL Diagnostics Appoints Eurobio Scientific as Exclusive Distributor for Its VELA Product Line in a Targeted Segment of the French Market | 420 | Business Wire | Regulatory News:
ABL Diagnostics (Euronext Paris: ABLD), a French company specializing in advanced molecular diagnostics, announces the signing of an exclusive distribution agreement with Eurobio... ► Artikel lesen | |
| 22.10.25 | ABL Diagnostics SA: ABL Diagnostics - Announcement of a Second Agreement Between ABL SA and Alumni Capital | 349 | Business Wire | Regulatory News:
ISIN: FR001400AHX6 Euronext Paris
ABL Diagnostics SA (the "Company") (Paris:ABLD) informs the public that Advanced Biological Laboratories SA (ABL SA), its parent company, announced... ► Artikel lesen |
1 2 Weiter >>
21 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SIEMENS HEALTHINEERS | 34,520 | +0,06 % | Großer Schritt geplant: Siemens Energy: Diese Abspaltung könnte zum nächsten Kursturbo werden | © Foto: Frank Rumpenhorst - dpaEin möglicher Verkauf der Industriesparte könnte bei Siemens Energy mehr Wert freisetzen, als der Kurs bisher zeigt. Analysten glauben: Das könnte erst der Anfang sein.Siemens... ► Artikel lesen | |
| THERMO FISHER | 409,90 | +0,89 % | If You Invested $100 In Thermo Fisher Scientific Stock 15 Years Ago, You Would Have This Much Today | ||
| STRATEC | 17,960 | -1,10 % | EQS-News: STRATEC SE: STRATEC-Hauptversammlung beschliesst Dividende und stimmt allen Beschlussvorschlägen zu | EQS-News: STRATEC SE
/ Schlagwort(e): Hauptversammlung
STRATEC-HAUPTVERSAMMLUNG BESCHLIESST DIVIDENDE UND STIMMT ALLEN BESCHLUSSVORSCHLÄGEN ZU
23.06.2026... ► Artikel lesen | |
| UNIDOC HEALTH | 0,057 | -8,04 % | UniDoc Health Corp.: UniDoc Connect Surpasses One Million Patient Visits | Company Records 250,000 Patient Visits in First Six Months Since AMD Purchase, Then Triples to 750,000 in the Following Six Months VANCOUVER, BC / ACCESS Newswire / June 9, 2026 / UniDoc Health Corp.... ► Artikel lesen | |
| DIASORIN | 65,04 | -0,70 % | Milan: Negative performance for DiaSorin | ||
| BIOCARTIS | - | - | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 21.01.2026 | The following instruments on Boerse Frankfurt do have their last trading day on 21.01.2026Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 21.01.2026ISIN NameBE0974281132 BIOCARTIS... ► Artikel lesen | |
| FRESENIUS | 39,900 | +0,91 % | DEUTSCHE BANK RESEARCH stuft Fresenius SE auf 'Buy' | FRANKFURT (dpa-AFX Analyser) - Deutsche Bank Research hat die Einstufung für Fresenius auf "Buy" mit einem Kursziel von 55 Euro belassen. Die Bedenken im Deutschen Bundesrat bezüglich staatlicher Kürzungen... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 41,550 | +0,73 % | AKTIE IM FOKUS: FMC schwächeln nach Abstufung - 200-Tage-Linie im Blick | FRANKFURT (dpa-AFX) - Die Aktien von FMC ringen nach einer Abstufung durch das Bankhaus Metzler am Freitag wieder um ihre zuletzt zurückeroberte einfache 200-Tage-Linie. Mit minus 2,6 Prozent fielen... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 66,83 | -0,55 % | BrightSpring Health Services, Inc. Reports First Quarter 2026 Financial Results and Increases Full Year 2026 Guidance | LOUISVILLE, Ky., May 01, 2026 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG), a leading provider of home and community-based health services... ► Artikel lesen | |
| BETA BIONICS | 13,670 | -0,22 % | Beta Bionics, Inc.: Beta Bionics Announces First Quarter 2026 Financial Results and Raises Full Year 2026 Guidance | IRVINE, Calif., April 21, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial... ► Artikel lesen | |
| HEARTSCIENCES | 2,750 | +55,37 % | Fortitude Mining Holdings, Inc. and HeartSciences Inc. Announce Business Combination, Aiming to Bring a Leading Vertically-Integrated Zcash Mining Platform to the Public Markets | FAIRPORT, N.Y.--(BUSINESS WIRE)--Fortitude Mining Holdings, Inc. ("Fortitude"), a vertically-integrated digital asset mining platform anchored in Zcash, and HeartSciences Inc. (Nasdaq: HSCS) ("HeartSciences")... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 26,940 | -1,75 % | DAX-Check LIVE: Brenntag, Carl Zeiss Meditec, DWS, Infineon, RWE, Vonovia im Fokus | Der deutsche Aktienmarkt hat den Wochenauftakt mit Gewinnen beendet. Der DAX schloss 0,6 Prozent fester bei 25.139 Punkten und verteidigte damit erneut die psychologisch wichtige Marke von 25.000 Zählern.... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 21,645 | +1,67 % | Alignment Healthcare Strengthens Leadership Team to Support Long-Term Growth and Shareholder Value Creation | ORANGE, Calif., May 12, 2026 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ: ALHC) today announced leadership updates that further strengthen the organization as the company continues to scale... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 20,600 | -2,18 % | PROCEPT BioRobotics Reports First Quarter 2026 Financial Results | SAN JOSE, Calif., April 29, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| GENEDX | 58,02 | +4,69 % | Piper Sandler raises GeneDx stock price target on coverage policy |
ABL DIAGNOSTICS SA gehört der Branche Gesundheitswesen an. Die relative Kursveränderung beträgt aktuell -1,68 % bei einem Aktienkurs von 2,340 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu ABL DIAGNOSTICS SA finden Sie auf Wallstreet Online.